FRED MERMELSTEIN

Profile

First Name

: FRED

Middle Name

:

Last Name

: MERMELSTEIN

Related Companies

Titles

Company Name

Related People

DIRECTOR

NX PHARMAGEN INC.

BRIAN BROHMAN, BRIAN D. BROHMAN, PASCAL DESCHATELETS, ALAN EZRIN, ALAN M. EZRIN, CEDRIC FRANCOIS, ROBERT SAUNDERS

DIRECTOR

ADVANTAGENE, INC.

LAURA AGUILAR, ESTUARDO AGUILAR-CORDOVA, EDWARD J. BENZ, MITCHELL FINER, PAUL MANNING, CHRIS MARTELL, GLENN MATTES, UDI MERAV, STEPHEN C. ROCAMBOLI, ALAN SMITH, SEAN STALFORT

DIRECTOR

NX DEVELOPMENT CORP.

BRIAN BROHMAN, ALAN EZRIN, ALAN M EZRIN, GREGORY MURDOCK, ROBERT SAUNDERS

DIRECTOR, PROMOTER

SANARX BIOTHERAPEUTICS, INC

CARL NOVINA, JULIA NOVINA, FREDERICK PIERCE

DIRECTOR

NEXTRNA THERAPEUTICS, INC.

KENNETH ANDERSON, ANDREA ARMSTRONG, ARTHUR BECKER, ALAIN COHEN, MARC A. COHEN, DREW DENNISON, CHRISTINE HENDERSON, SUSAN LANGER, CARL NOVINA, JULIA A. NOVINA, BARRY POLISKY, ELENA PROKUPETS, MALCOLM SALTER, DOMINIQUE VERHELLE

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-01-12

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2020-08-17

D

BIOTECHNOLOGY

NO REVENUES

Equity

2019-09-23

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-08-31

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-06-30

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-05-31

D

BIOTECHNOLOGY

$1 - $1,000,000

Equity

2016-05-16

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-04-05

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-04-05

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2015-12-04

D

OTHER HEALTH CARE

NO REVENUES

Debt

2013-06-24